National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, & ebrary, Inc. (2011). Risk-characterization framework for decision-making at the food and drug administration. National Academies Press.
Uspješno je kopirano u međuspremnik
Kopiranje u međuspremnik neuspjelo
Čikaški stil citiranja (17. izdanje)
National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, i Inc ebrary. Risk-characterization Framework for Decision-making at the Food and Drug Administration. Washington, DC: National Academies Press, 2011.
Uspješno je kopirano u međuspremnik
Kopiranje u međuspremnik neuspjelo
MLA način citiranja (9. izdanje)
National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, i Inc ebrary. Risk-characterization Framework for Decision-making at the Food and Drug Administration. National Academies Press, 2011.
Uspješno je kopirano u međuspremnik
Kopiranje u međuspremnik neuspjelo
Upozorenje: Ovi citati možda nisu uvijek 100% točni.